Stefan T. Wills
Chairman
Business Management
MediWound
Israel
Biography
Mr. Wills currently serves as the chief financial officer and chief operating officer of Palatin Technologies, Inc., a publicly-held biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases in the fields of sexual dysfunction, anti-inflammatory targets and heart failure. He possesses extensive financial, operational and healthcare experience. Mr. Wills served as executive chairman and interim principal executive officer of Derma Sciences, Inc., a publicly-held company providing advanced wound care products, from December 2015 until February 2017 when Derma Sciences was acquired by Integra Life Sciences. Mr. Wills also served as the lead director until December 2015. Mr. Wills currently serves on the board of trustees and executive committee of The Hun School of Princeton. Mr. Wills, a certified public accountant, earned his B.S. in accounting from West Chester University, and an M.S. in taxation from Temple University.
Research Interest
Business Management
